Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Cancer Research|September 1, 1979
Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivativesP M Kanter, H S SchwartzCancer Treatment Reports|May 1, 1979
Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agentsH S Schwartz, P M KanterMolecular Pharmacology|July 1, 1982
A fluorescence enhancement assay for cellular DNA damageP M Kanter, H S SchwartzCancer Research|February 1, 1979
Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cellsP M Kanter, H S SchwartzInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|November 1, 1980
Post-repair DNA damage in X-irradiated cultured human tumour cellsP M Kanter, H S SchwartzCancer Letters|September 1, 1981
DNA damage by anthracycline drugs in human leukemia cellsH S Schwartz, P M KanterAntibiotics and Chemotherapy|January 1, 1978
Mechanisms of selectivity of intercalating agentsH S Schwartz, G Schioppacassi, P M KanterCancer Drug Delivery|January 1, 1983
Functional and chemical markers of PCNU activityP M Kanter, H S Schwartz, C R WestAnnals of Surgery|March 1, 1978
Comparison of regional versus systemic chemotherapy with adriamycinM S Didolkar, P M Kanter, R R Baffi, et al.Anti-Cancer Drugs|February 1, 1995
Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigenG M Klaich, P M KanterPageof 10